Acfp Berne - Medicare Primary Care in Berne, IN

Acfp Berne is a medicare enrolled primary clinic (Family Medicine) in Berne, Indiana. The current practice location for Acfp Berne is 1521 W Main St, Berne, Indiana. For appointments, you can reach them via phone at (260) 589-3993. The mailing address for Acfp Berne is 1521 W Main St, Berne, Indiana and phone number is (260) 589-3993.

Acfp Berne is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1902077985. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (260) 589-3993.

Contact Information

Acfp Berne
1521 W Main St
Berne
IN 46711-1796
(260) 589-3993
(260) 589-2070

Primary Care Clinic Profile

Full NameAcfp Berne
SpecialityFamily Medicine
Location1521 W Main St, Berne, Indiana
Authorized Official Name and PositionKent A Lehman (PRESIDENT)
Authorized Official Contact2605893993
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Acfp Berne
1521 W Main St
Berne
IN 46711-1796

Ph: (260) 589-3993
Acfp Berne
1521 W Main St
Berne
IN 46711-1796

Ph: (260) 589-3993

NPI Details:

NPI Number1902077985
Provider Enumeration Date03/18/2008
Last Update Date03/11/2014

Medicare PECOS Information:

Medicare PECOS PAC ID7315023181
Medicare Enrollment IDO20080320000107

News Archive

Researchers evaluate short- and long-term employment impacts to ICU patients

In recent years, national attention has been drawn to the plight of patients who have experienced the unintended side effects of prolonged ICU care, such as memory loss, muscle weakness and depression.

AstraZeneca, Rigel enter global license agreement for R256 inhaled JAK inhibitor to treat chronic asthma

AstraZeneca and Rigel Pharmaceuticals Inc. today announced an exclusive worldwide license agreement for the global development and commercialization of R256, Rigel's inhaled JAK inhibitor shown to inhibit IL-13 and IL-4 signalling, which is being investigated as a treatment for moderate to severe chronic asthma. In preclinical research, R256 has been shown to reduce airway inflammation and improve lung function.

MSU team designs innovative medical diagnosis system

A Michigan State University engineering design team has developed a medical diagnosis system that would allow people to be inexpensively screened for a variety of medical problems.

Fracture risk increases by 30% after gastric bypass, study shows

A study published in the Journal of Bone and Mineral Research shows that the risk of fractures increases by about 30 percent after a gastric bypass operation. It was also discovered that falls increase after these operations.

Read more Medical News

› Verified 8 days ago

Medical Identifiers

Medical identifiers for Acfp Berne such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1902077985NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207Q00000XFamily Medicine (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Acfp Berne acts as a billing entity for following providers:
Provider NameKent A Lehman
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1619905395
PECOS PAC ID: 1951290980
Enrollment ID: I20040315001104

News Archive

Researchers evaluate short- and long-term employment impacts to ICU patients

In recent years, national attention has been drawn to the plight of patients who have experienced the unintended side effects of prolonged ICU care, such as memory loss, muscle weakness and depression.

AstraZeneca, Rigel enter global license agreement for R256 inhaled JAK inhibitor to treat chronic asthma

AstraZeneca and Rigel Pharmaceuticals Inc. today announced an exclusive worldwide license agreement for the global development and commercialization of R256, Rigel's inhaled JAK inhibitor shown to inhibit IL-13 and IL-4 signalling, which is being investigated as a treatment for moderate to severe chronic asthma. In preclinical research, R256 has been shown to reduce airway inflammation and improve lung function.

MSU team designs innovative medical diagnosis system

A Michigan State University engineering design team has developed a medical diagnosis system that would allow people to be inexpensively screened for a variety of medical problems.

Fracture risk increases by 30% after gastric bypass, study shows

A study published in the Journal of Bone and Mineral Research shows that the risk of fractures increases by about 30 percent after a gastric bypass operation. It was also discovered that falls increase after these operations.

Read more Medical News

› Verified 8 days ago

Provider NameTamara J Reynolds
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1336237320
PECOS PAC ID: 2365576105
Enrollment ID: I20100817000096

News Archive

Researchers evaluate short- and long-term employment impacts to ICU patients

In recent years, national attention has been drawn to the plight of patients who have experienced the unintended side effects of prolonged ICU care, such as memory loss, muscle weakness and depression.

AstraZeneca, Rigel enter global license agreement for R256 inhaled JAK inhibitor to treat chronic asthma

AstraZeneca and Rigel Pharmaceuticals Inc. today announced an exclusive worldwide license agreement for the global development and commercialization of R256, Rigel's inhaled JAK inhibitor shown to inhibit IL-13 and IL-4 signalling, which is being investigated as a treatment for moderate to severe chronic asthma. In preclinical research, R256 has been shown to reduce airway inflammation and improve lung function.

MSU team designs innovative medical diagnosis system

A Michigan State University engineering design team has developed a medical diagnosis system that would allow people to be inexpensively screened for a variety of medical problems.

Fracture risk increases by 30% after gastric bypass, study shows

A study published in the Journal of Bone and Mineral Research shows that the risk of fractures increases by about 30 percent after a gastric bypass operation. It was also discovered that falls increase after these operations.

Read more Medical News

› Verified 8 days ago

News Archive

Researchers evaluate short- and long-term employment impacts to ICU patients

In recent years, national attention has been drawn to the plight of patients who have experienced the unintended side effects of prolonged ICU care, such as memory loss, muscle weakness and depression.

AstraZeneca, Rigel enter global license agreement for R256 inhaled JAK inhibitor to treat chronic asthma

AstraZeneca and Rigel Pharmaceuticals Inc. today announced an exclusive worldwide license agreement for the global development and commercialization of R256, Rigel's inhaled JAK inhibitor shown to inhibit IL-13 and IL-4 signalling, which is being investigated as a treatment for moderate to severe chronic asthma. In preclinical research, R256 has been shown to reduce airway inflammation and improve lung function.

MSU team designs innovative medical diagnosis system

A Michigan State University engineering design team has developed a medical diagnosis system that would allow people to be inexpensively screened for a variety of medical problems.

Fracture risk increases by 30% after gastric bypass, study shows

A study published in the Journal of Bone and Mineral Research shows that the risk of fractures increases by about 30 percent after a gastric bypass operation. It was also discovered that falls increase after these operations.

Read more News

› Verified 8 days ago


Family Medicine in Berne, IN

Adams County Memorial Hospital
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 1521 W Main St, Berne, IN 46711
Phone: 260-724-2145    
Everside Health, Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 926 W. 500 S., Berne, IN 46711
Phone: 260-849-4296    Fax: 260-849-4298
Robert Judge
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1521 W Main St, Berne, IN 46711
Phone: 260-589-2312    
Acfp Berne
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1521 W Main St, Berne, IN 46711
Phone: 260-589-3993    Fax: 260-589-2070

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.